





































































































































































































































































































































































































































































































































































































































































	 X	=	1	–	Σd	(Sd	+	Rd)	 	 	 	 	 	 	 (3)	619 
	620 
where	𝑞( 	is	the	strength	of	diversifying	selection	for	D-type	𝑑	 ∈ 	 {1,2, … , 𝐷}	and	𝑢( 	is	621 
the	clearance	rate	for	D-type	d.	We	follow	Lehtinen	et	al.	(38)	in	defining		𝑞( =622 
(1 − )&*+&∑ -)'*+'.(')%
+ /
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βD𝑓𝐴454|6 + (1 − 𝑓)∑ ℎℓ𝐴454|ℓ8ℓ9/ I,	where	β	is	the	transmission	rate,	f	is	the	between-649 






country	m	is	𝜆3,! = β?𝑓 ?𝑔𝐴454|6,! + (1 − 𝑔)∑
/
;




































(𝜏/, 𝜏>, … , 𝜏8),	𝑟 = (𝑟/, 𝑟>, … , 𝑟8),	and	𝑛 = (𝑛/, 𝑛>, … , 𝑛8),	respectively.	The	probability	of	687 
a	given	set	of	model	parameters	𝜃	is	then	688 
𝑃(𝜃|𝜏, 𝑟, 𝑛) ∝ 𝑃(𝜏, 𝑟, 𝑛|𝜃)𝑃(𝜃),	689 
	690 
where	𝑃(𝜃)	is	the	prior	probability	of	parameters	𝜃	and	691 











mean	0.5	and	standard	deviation	0.002.	For	R(r,n,ρ),	we	use	𝑅(𝑟, 𝑛, 𝜌) =699 
∫ 𝑇D𝑥|𝜇 = 𝜌, 𝜎 = 𝜎(𝜃)IDABI𝑥
B(1 − 𝑥)A2B 	𝑑𝑥/C ,	a	binomial	distribution	where	the	700 
probability	of	success	is	modelled	as	a	[0,1]-truncated	normal	distribution	centred	on	ρ	701 
and	with	standard	deviation	σ.	The	parameter	σ	captures	the	unexplained	between-702 
country	variation	in	resistance	frequency.	Here,	𝑇(𝑥|𝜇, 𝜎) = D(F|G,H)
-J(/|G,H)2J(C|G,H).
,	where	703 
















As	prior	distributions	for	parameter	inference,	we	adopted	𝑐 ∼ Beta(𝛼 = 1.5, 𝛽 = 8.5),	711 
𝑏 ∼ Gamma(𝜅 = 2, 𝜃 = 0.5),	𝛽 ∼ Gamma(𝜅 = 5, 𝜃 = 0.35),	𝑔 ∼ Beta(𝛼 = 10, 𝛽 = 1.5),	712 
 23 
𝜅 ∼ Gamma(𝜅 = 4, 𝜃 = 2),	𝑎 ∼ Gamma(𝜅 = 2, 𝜃 = 5),	𝛿 ∼ Beta(𝛼 = 20, 𝛽 = 25),	and	713 













































𝑃(𝜏, 𝑟, 𝑛|𝜃) = 𝐶D𝑌 = 𝑌(𝜏|𝜃)IR𝜙w𝜇 = 𝑟6 + 1𝑛6 + 2









































































































































































































































































































































































































































































WAIC: 246.4 ± 67.3 244.2 ± 66.4 248.3 ± 67.4 247.6 ± 67.2
Treatment diversity Pathogen diversity Treatment competition Growth competition
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How potential for coexistence is calculated
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